Chris Skedgel
Visiting Scientist
Dr Chris Skedgel has over 25 years of applied health economics experience in consulting and academia. His interests centre on the use of health economics to maximise the societal value of scarce healthcare resources, including economic modelling of value-for-money, and stated preference methods to understand patient and public values. He has more than 60 peer–reviewed publications on topics including cost–effectiveness evaluations, stated preference studies, methodological contributions, issue commentaries, and invited editorials.
Chris is a Director with the Office of Health Economics, a health economics consultancy and Independent Research Organisation in London UK, and is an Honorary Research Fellow with the Health Economics Group at the University of East Anglia, UK. He currently sits on the editorial board of Pharmacoeconomics. He has a PhD in Health Economics & Decision Science from The University of Sheffield and a Master’s degree in Development Economics from Dalhousie University, Canada.
His recent work includes a study of the relative importance of different aspects of end-of-life care, and commentaries on understanding the value of fertility treatments and modelling spillover effects on informal carers in HTA (“the Carer QALY Trap”).